Your most critical assets deserve more than just fences and cameras. NV5’s cutting-edge layered security solutions extend detection and response beyond traditional perimeters. From advanced geospatial analytics to integrated surveillance and access control, NV5 helps you stay ahead of threats before they breach your defenses. Learn more.

Learn More

Research & Applications

NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Nieh confirmed for the NRC

November 19, 2025, 3:00PMNuclear News

Earlier today, the U.S. Senate officially confirmed Ho Nieh in a 66–32 vote to serve as a commissioner on the U.S. Nuclear Regulatory Commission through the remainder of a term that will...

New financing round benefits Valar

November 13, 2025, 3:00PMNuclear News

Hawthorne, Calif.–based reactor start-up Valar Atomics recently announced that it has raised $130 million in its Series A funding round, led by venture capital groups Snowpoint, Day One, and...

X-energy begins irradiation testing at INL

November 12, 2025, 3:01PMNuclear News

Advanced reactor and fuel developer X-energy has officially begun confirmatory irradiation testing at Idaho National Laboratory on its TRISO-X fuel. The testing, which is taking place over the...